首页>
外国专利>
Use of interleukin 1 receptor antagonist and / or pyrrolidine dithiocarbamate for treating or preventing type II diabetes
Use of interleukin 1 receptor antagonist and / or pyrrolidine dithiocarbamate for treating or preventing type II diabetes
展开▼
机译:白介素1受体拮抗剂和/或吡咯烷二硫代氨基甲酸酯在治疗或预防II型糖尿病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Substances that inhibit the action of the members of the IL-1beta/NF-kappaB pathway can be used for protecting and preserving beta-cell mass and function in prediabetic and diabetic type 2 patients. Specifically, the present invention relates to the use of an Interleukin 1 receptor antagonist (IL-1Ra) and/or pyrrolidinedithiocarbamate (PDTC) for the treatment or prophylaxis of type 2 diabetes, as well as a method for the treatment of type 2 diabetes.
展开▼